Skip to main content
SpringerLink
Log in

Decrease in hypothalamic epinephrine concentration and other neurochemical changes produced by quinpirole, a dopamine agonist, in rats

  • Original Papers
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

Quinpirole, (4 aR-trans)-4, 4 a, 5, 6, 7, 8, 8a, 9-octahydro-5-propyl-1 H-pyrazolo[3, 4-g] quinoline, is a dopamine agonist selective for the D2 subtype of dopamine receptors. In rats, quinpirole at doses of 0.3 mg/kg i.p. and higher decreased hypothalamic epinephrine concentrations. The doses required for this effect are only slightly higher than the minimum doses that decreased the concentration of dopamine metabolites in cerebral hemispheres. At higher doses of quinpirole (2–3 mg/kg i.p.), dopamine concentration was increased and norepinephrine concentration was decreased in hypothalamus, and MHPG sulfate (the norepinephrine metabolite) concentration was increased in brain stem and in hypothalamus. All of these neurochemical effects of quinpirole were blocked by pretreatment with spiperone, a dopamine antagonist. The effects were not produced by SKF 38393, a selective D1 agonist, or by the dextrorotatory enantiomer of quinpirole, which lacks D2 agonist activity. The data support the interpretation that quinpirole, by activating D2 receptors, results in a decrease in dopamine metabolites, a decrease in hypothalamic epinephrine concentration, and an increased conversion of norepinephrine to MHPG sulfate in rat brain probably through enhanced norepinephrine release.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

DOPAC:

3, 4-dihydroxyphenylacetic acid

HVA:

homovanillic acid

MHPG:

3-methoxy-4-hydroxy-phenylethyleneglycol

References

  • Bach, N. J., Kornfeld, E. C. Jones, N. D., Chaney, M. D., Dorman, D. E., Paschal, J. W., Clemens, J. A., Smalstig, E. B.: Bicyclic and tricyclic ergoline partial structures. Rigid 3-(2-aminoethyl)pyroles and 3- and 4-(2-aminoethyl)-pyrazoles as dopamine agonists. J. Med. Chem.23, 481–491 (1980).

    PubMed  Google Scholar 

  • Baumann, P. A., Waldmeier, P. C.: The effects of the blockade of presynapticα-receptors by yohimbine and mianserine on the levels of 4-hydroxy-3-methoxyphenylethyleneglycol sulphate (MOPEG-SO4) in different brain regions of the rat: Influence of mianserine on daily rhythm in MOPEG-SO4 level. Experientia34, 992 (1980).

    Google Scholar 

  • Braestrup, C., Nielsen, M.: Regulation in the central norepinephrine neurotransmission inducedin vivo byalpha adrenoceptor active drugs. J. Pharmacol. Exp. Ther.198, 596–608 (1976).

    PubMed  Google Scholar 

  • Burki, H. R., Asper, H., Ruch, W., Zuger, P. E.: Bromocriptine, dihydroergotoxine, methysergide, d-LSD, CF 25-397, and 29-712: Effects on the metabolism of the biogenic amines in the brain of the rat. Psychopharmacology57, 227–237 (1978).

    PubMed  Google Scholar 

  • Cavero, I.: Cardiovascular effects of LY141865, a new dopamine receptor agonist, in rats. Brit. J. Pharmacol.78, 139 P (1983).

    Google Scholar 

  • Fuller, R. W., Clemens, J. A., Kornfeld, E. C., Snoddy, H. D., Smalstig, E. B., Bach, N. J.: Effects of (8β)-8-[(methylthio)methyl]-6-propylergoline on dopaminergic function and brain dopamine turnover in rats. Life Sci.24, 375–382 (1979 a).

    PubMed  Google Scholar 

  • Fuller, R. W., Hemrick-Luecke, S. K., Wong, D. T., Pearson, D., Threlkeld, P. G., Hynes, M. D. III.: Altered behavioral response to a D2 agonist, LY141865, in spontaneously hypertensive rats exhibiting biochemical and endocrine responses similar to those in normotensive rats. J. Pharmacol. Exp. Ther.227, 354–359 (1983 a).

    PubMed  Google Scholar 

  • Fuller, R. W., Perry, K. W.: Lowering of epinephrine concentration in rat brain by 2, 3-dichloro-α-methylbenzylamine, an inhibitor of norepinephrine N-methyltransferase. Biochem. Pharmacol.26, 2087–2090 (1977).

    PubMed  Google Scholar 

  • Fuller, R. W., Perry, K. W.: Effect of pergolide on MOPEG sulphate levels in rat brain regions. J. Pharm. Pharmacol.35, 57–58 (1983).

    PubMed  Google Scholar 

  • Fuller, R. W., Perry, K. W., Hemrick, S. K.: Pharmacologic manipulation of epinephrine concentration in rat brain. Fed. Proc.38, 421 (1976 b).

    Google Scholar 

  • Fuller, R. W., Perry, K. W., Hemrick-Euecke, S. K.: Depletion of epinephrine in rat hypothalamus by a dopamine agonist, pergolide. Neurochem. Res.7, 399–405 (1982).

    PubMed  Google Scholar 

  • Fuller, R. W., Snoddy, H. D., Hemrick-Luecke, S. K.: Increase in serum corticosterone concentration and decrease in hypothalamic epinephrine concentration by N-propylnorapomorphine in rats. Biochem. Pharmacol.33, 1372–1374 (1984).

    PubMed  Google Scholar 

  • Fuller, R. W., Snoddy, H. D., Mason, N. R., Clemens, J. A., Bemis, K. G.: Elevation of serum corticosterone in rats by dopamine agonists related in structure to pergolide. Neuroendocrinology36, 285–290 (1983 b).

    PubMed  Google Scholar 

  • Fuller, R. W., Snoddy, H. D., Perry, K. W.: Effect of prazosin on norepinephrine concentration and turnover in rat brain and heart. Arch. int. Pharmacodyn.231, 30–41 (1978).

    PubMed  Google Scholar 

  • Goldstein, M., Kinugasa, K.: The antihypertensive action of a presynaptic dopamine agonist, LY141865. The Pharmacologist24, 137 (1982).

    Google Scholar 

  • Hahn, R. A., MacDonald, B. R., Martin, M. A.: Antihypertensive activity of LY141865, a selective presynaptic dopamine receptor agonist. J. Pharmacol. Exp. Ther.224, 206–214 (1983).

    PubMed  Google Scholar 

  • Jadhav, A. L., Willett, R. N., Sapru, H. N., Lokhandwala, M. F.: Involvement of central dopamine receptors in the hypotensive action of pergolide. Naunym-Schmiedeberg's Arch. Pharmacol.324, 281–286 (1983).

    Google Scholar 

  • Kebabian, J. W., Beaulieu, M., Itoh, Y.: Pharmacological and biochemical evidence for the existence of two categories of dopamine receptor. Canad. J. Neurol. Sci.11, 114–117 (1984).

    PubMed  Google Scholar 

  • McPherson, G. A., Beart, P. M.: The selectivity of some ergot derivatives forα 1 andα 2-adrenoceptors of rat cerebral cortex. Eur. J. Pharmacol.91, 363–369 (1983).

    PubMed  Google Scholar 

  • Mezey, E., Kiss, J. Z., Skirboll, L. R., Goldstein, M., Axelrod, J.: Increase of corticotropin-releasing factor staining in rat paraventricular nucleus neurones by depletion of hypothalamic adrenaline. Nature310, 140–141 (1984).

    PubMed  Google Scholar 

  • Perry, K. W., Fuller, R. W.: Analysis of biogenic amine metabolites in rat brain by HPLC with electrochemical detection. Soc. Neurosci. Abstr.5, 348 (1979).

    Google Scholar 

  • Fieri, L., Keller, H. H., Burkard, W., Da Prada, M.: Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis. Nature272, 278–280 (1978).

    PubMed  Google Scholar 

  • Rabey, J. M., Passeltiner, P., Markey, K., Asano, T., Goldstein, M.: Stimulation of pre- and postsynaptic dopamine receptors by an ergoline and by a partial ergoline. Brain Res.225, 347–359 (1981).

    PubMed  Google Scholar 

  • Sauter, A., Ueta, K., Goldstein, M.: Effect of DBH- and PNMT-inhibition on brain adrenaline and noradrenaline in animals exposed to stress. In: Central Adrenaline Neurons: Basic Aspects and Their Role in Cardiovascular Functions (Fuxe, K., Goldstein, M., Hokfelt, B., Hokfelt, T., eds.), pp. 97–103. Oxford: Pergamon Press. 1980.

    Google Scholar 

  • Saavedra, J. M., Grobecker, H., Axelrod, J.: Adrenaline-forming enzyme in brain stem: Elevation in genetic and experimental hypertension. Science191, 483–484 (1976).

    PubMed  Google Scholar 

  • Scatton, B.: Further evidence for the involvement of D2, but not D1 dopamine receptors in dopaminergic control of striatal cholinergic transmission. Life Sci.31, 2883–2890 (1982).

    PubMed  Google Scholar 

  • Scatton, B., Zivkovic, B., Dedek, J.: Antidopaminergic properties of yohimbine. J. Pharmacol. Exp. Ther.215, 494–499 (1980).

    PubMed  Google Scholar 

  • Setler, P. E., Sarau, H. M., Zirkle, C. L., Saunders, H. L.: The central effects of a novel dopamine agonist. Eur. J. Pharmacol.50, 419–430 (1978).

    PubMed  Google Scholar 

  • Titus, R. D., Kornfeld, E. C., Jones, N. D., Clemens, J. A., Smalstig, E. B., Fuller, R. W., Hahn, R. A., Hynes, M. D., Mason, N. R., Wong, D. T., Foreman, M. M.: Resolution and absolute configuration of an ergoline-related dopamine agonist, trans-4, 4 a, 5, 6, 7, 8, 8 a, 9-octahydro-5-propyl-1H(or 2H)-pyrazolo[3, 4-g] quinoline. J. Med. Chem.26, 1112–1116 (1983).

    PubMed  Google Scholar 

  • Tsuruta, K., Frey, E. A., Grewe, C. W., Cote, T. E., Eskay, R. L., Kebabian, J. W.: Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor. Nature292, 463–465 (1981).

    PubMed  Google Scholar 

  • Wong, D. T., Bymaster, F. P., Reid, L. R., Fuller, R. W., Perry, K. W., Kornfeld, E. C.: Effect of a stereospecific D2-dopamine agonist on acetylcholine concentration in corpus striatum of rat brain. J. Neural Transm.58, 55–67 (1983).

    PubMed  Google Scholar 

Download references

Author information

Author notes

  1. R. W. Fuller

    Present address: Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA

Authors and Affiliations

  1. Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA

    Susan K. Hemrick-Luecke

Authors
  1. R. W. Fuller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susan K. Hemrick-Luecke
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fuller, R.W., Hemrick-Luecke, S.K. Decrease in hypothalamic epinephrine concentration and other neurochemical changes produced by quinpirole, a dopamine agonist, in rats. J. Neural Transmission 61, 161–173 (1985). https://doi.org/10.1007/BF01251910

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01251910

Keywords

Search

Navigation